Damián E. Berardi

480 total citations
15 papers, 361 citations indexed

About

Damián E. Berardi is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Damián E. Berardi has authored 15 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Damián E. Berardi's work include Retinoids in leukemia and cellular processes (5 papers), Autophagy in Disease and Therapy (4 papers) and Estrogen and related hormone effects (4 papers). Damián E. Berardi is often cited by papers focused on Retinoids in leukemia and cellular processes (5 papers), Autophagy in Disease and Therapy (4 papers) and Estrogen and related hormone effects (4 papers). Damián E. Berardi collaborates with scholars based in Argentina, United States and Cuba. Damián E. Berardi's co-authors include Laura B. Todaro, Elisa Bal de Kier Joffé, Kay F. Macleod, Alejandro J. Urtreger, Logan P. Poole, Marina Simian, Gabriel L. Fiszman, Stéfano M. Cirigliano, Grazyna Bozek and Leonard Lothstein and has published in prestigious journals such as Scientific Reports, Science Advances and Cancer Letters.

In The Last Decade

Damián E. Berardi

15 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Damián E. Berardi Argentina 11 207 116 110 70 40 15 361
Junye Chen China 11 197 1.0× 101 0.9× 75 0.7× 91 1.3× 29 0.7× 26 420
Xu Tian China 11 233 1.1× 57 0.5× 45 0.4× 88 1.3× 32 0.8× 23 376
Vasudha Sehgal United States 7 307 1.5× 117 1.0× 85 0.8× 172 2.5× 27 0.7× 11 503
Stacey L. Lehman United States 7 262 1.3× 81 0.7× 80 0.7× 89 1.3× 120 3.0× 12 394
HyeRan Gwak South Korea 8 245 1.2× 71 0.6× 78 0.7× 108 1.5× 57 1.4× 10 383
Xianshu Huang United States 5 317 1.5× 82 0.7× 52 0.5× 61 0.9× 37 0.9× 7 452
Nicole A. Traphagen United States 12 203 1.0× 120 1.0× 42 0.4× 98 1.4× 19 0.5× 15 360
Zhiwei Chen China 11 294 1.4× 110 0.9× 38 0.3× 128 1.8× 27 0.7× 24 404
Sofia Giacosa France 5 258 1.2× 106 0.9× 75 0.7× 26 0.4× 16 0.4× 7 407

Countries citing papers authored by Damián E. Berardi

Since Specialization
Citations

This map shows the geographic impact of Damián E. Berardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damián E. Berardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damián E. Berardi more than expected).

Fields of papers citing papers by Damián E. Berardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damián E. Berardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damián E. Berardi. The network helps show where Damián E. Berardi may publish in the future.

Co-authorship network of co-authors of Damián E. Berardi

This figure shows the co-authorship network connecting the top 25 collaborators of Damián E. Berardi. A scholar is included among the top collaborators of Damián E. Berardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damián E. Berardi. Damián E. Berardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Berardi, Damián E., et al.. (2022). Lipid droplet turnover at the lysosome inhibits growth of hepatocellular carcinoma in a BNIP3-dependent manner. Science Advances. 8(41). eabo2510–eabo2510. 18 indexed citations
2.
Filho, Helder Veras Ribeiro, Germán G. Sgro, Fernanda Aparecida Heleno Batista, et al.. (2022). Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCγ as an analgesic drug target. Science Signaling. 15(731). eabm6046–eabm6046. 5 indexed citations
3.
Poole, Logan P., et al.. (2021). ULK1 promotes mitophagy via phosphorylation and stabilization of BNIP3. Scientific Reports. 11(1). 20526–20526. 75 indexed citations
4.
Berardi, Damián E., Stéfano M. Cirigliano, Alexis Edelstein, et al.. (2021). All-trans retinoic acid and protein kinase C α/β1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression. Scientific Reports. 11(1). 6044–6044. 7 indexed citations
5.
Berardi, Damián E., et al.. (2020). Protein Kinase C Alpha (PKCα) overexpression leads to a better response to retinoid acid therapy through Retinoic Acid Receptor Beta (RARβ) activation in mammary cancer cells. Journal of Cancer Research and Clinical Oncology. 146(12). 3241–3253. 10 indexed citations
6.
Berardi, Damián E., et al.. (2017). Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture. Journal of Cellular Biochemistry. 119(2). 1381–1391. 42 indexed citations
7.
Cirigliano, Stéfano M., Damián E. Berardi, Elisa Bal de Kier Joffé, et al.. (2017). The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines. Cancer Cell International. 17(1). 42–42. 12 indexed citations
8.
Berardi, Damián E., et al.. (2016). Laminin Modulates the Stem Cell Population in LM05-E Murine Breast Cancer Cells through the Activation of the MAPK/ERK Pathway. Cancer Research and Treatment. 49(4). 869–879. 15 indexed citations
9.
Brantley, Eileen, Damián E. Berardi, Marina Simian, et al.. (2016). AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity. Cancer Letters. 376(1). 53–61. 34 indexed citations
10.
Berardi, Damián E., et al.. (2015). Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid. Cellular Oncology. 38(4). 289–305. 15 indexed citations
11.
Berardi, Damián E., Stéfano M. Cirigliano, Elisa Bal de Kier Joffé, et al.. (2015). PKCδ Inhibition Impairs Mammary Cancer Proliferative Capacity But Selects Cancer Stem Cells, Involving Autophagy. Journal of Cellular Biochemistry. 117(3). 730–740. 22 indexed citations
12.
Berardi, Damián E., et al.. (2014). Involvement of protein kinase C α and δ activities on the induction of the retinoic acid system in mammary cancer cells. Molecular Carcinogenesis. 54(10). 1110–1121. 9 indexed citations
13.
Berardi, Damián E., et al.. (2013). Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate. Breast Cancer Research and Treatment. 142(3). 537–548. 29 indexed citations
14.
Berardi, Damián E., et al.. (2011). Autophagy: Friend or Foe in Breast Cancer Development, Progression, and Treatment. International Journal of Breast Cancer. 2011. 1–7. 44 indexed citations
15.
Berardi, Damián E., et al.. (2010). Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs. Breast Cancer Research and Treatment. 126(3). 577–587. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026